These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 546716)

  • 21. [Calcium metabolism in arterial hypertension. II. Changes in thrombocyte sensitivity to verapamil].
    Atakhanov ShE; Tkhostova EB; Iurenev AP; Men'shikov MIu; Mazaev AV
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):28-32. PubMed ID: 3401337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new sustained-release formulation of verapamil in the treatment of hypertension.
    Midtbo KA; Hals O; Lauve O
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):125S-132S. PubMed ID: 3540222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Action of verapamil as a hypotensive agent - analysis of the arterial pressure curve in the cycloergometric test].
    Candau LA; Tasca R; Carvalho DM; Scherr C
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():18-23. PubMed ID: 7325859
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of diuretic-resistant arterial hypertension - crossed comparative study of verapamil and clonidine].
    Maciel RM; Spritzer N; Spritzer TS; Abichequer MB
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():47-50. PubMed ID: 7034700
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical evaluation of the effect of verapamil in hypertensive patients].
    Gelman A; de Albuquerque EM; Reynaldo Stella S; Draibe SA; Ajzen H
    Arq Bras Cardiol; 1983 Jan; 40(1):69-71. PubMed ID: 6351814
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparison of the effect of short-term treatment with nifedipine and verapamil on blood pressure, plasma atrial natriuretic peptide (ANP) and cyclic guanosine monophosphate (cGMP) in patients with primary arterial hypertension I degree according to WHO].
    Widecka K; Marzecka J; Goździk J; Gruszczyńska M; Ciechanowski K; Czekalski S
    Pol Tyg Lek; 1994 Mar 7-14; 49(10-11):228-30. PubMed ID: 7862584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Verapamil as a hypotensive agent. Clinical, laboratory, electro- and echocardiographic study].
    Talberg J; Fernandes EO; Chequer CV; Latreca CE; Reis NB
    Arq Bras Cardiol; 1981 Mar; 36 Suppl 1():36-40. PubMed ID: 7325861
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effects of verapamil on cardiac performance].
    Câmpeanu A; Cerin G; Chira R; Pleşa O; Chirilă L
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):87-96. PubMed ID: 6145210
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of verapamil in the treatment of hypertension.
    Anavekar SN; Doyle AE
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):90S-99S. PubMed ID: 3540229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypertension in a patient with hypercalcemia: captopril and verapamil.
    Waeber B; Brunner HR; Burckhardt P; Gavras H
    Arch Intern Med; 1982 Jan; 142(1):143-5. PubMed ID: 7032443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of a slow channel inhibitor, verapamil, in the management of hypertension.
    Gould BA; Mann S; Kieso H; Balasubramanian V; Raftery EB
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():113-21. PubMed ID: 6956472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enalapril and verapamil in the treatment of isolated systolic hypertension in the elderly.
    Espinel CH; Bruner DE; Davis JR; Williams JL
    Clin Ther; 1992; 14(6):835-44. PubMed ID: 1286492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes in the functional level of baroreceptors under the action of verapamil in arterial hypertension].
    Luna RL; Arslanian L; de Souza EM; de Oliveira PS
    Arq Bras Cardiol; 1988 Oct; 51(4):297-303. PubMed ID: 3251456
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparative study of the combination of chlorthalidone with verapamil and metoprolol in arterial hypertension: evaluation by cycloergometrics].
    Candau LA; Pereira LS; Scherr C
    Arq Bras Cardiol; 1981 Aug; 37(2):133-8. PubMed ID: 6753801
    [No Abstract]   [Full Text] [Related]  

  • 35. The effect of short-term oral verapamil on exercise hemodynamics and oxygen delivery in patients with hypertension.
    Cody RJ; Kubo SH; Laragh JH
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):47S-54S. PubMed ID: 3794765
    [No Abstract]   [Full Text] [Related]  

  • 36. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
    Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
    J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of verapamil on renal blood flow, renal function, and neurohormonal profiles in patients with moderate to severe hypertension.
    Kubo SH; Cody RJ; Covit AB; Feldschuh J; Laragh JH
    J Clin Hypertens; 1986 Sep; 2(3 Suppl):38S-46S. PubMed ID: 3794764
    [No Abstract]   [Full Text] [Related]  

  • 38. Hydrochlorothiazide and verapamil in the treatment of hypertension. The Verapamil Versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 6():S33-7. PubMed ID: 1725915
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antihypertensive effect of long-term oral therapy with verapamil in elderly patients].
    Rotolo V; Lombardo F; Cicuttini L; Moratti P
    Clin Ter; 1985 Mar; 112(5):453-6. PubMed ID: 4017470
    [No Abstract]   [Full Text] [Related]  

  • 40. Hypertension with orthostatic hypotension: interest of verapamil.
    Chamontin BF; Montastruc JL; Salvador MJ
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S114-6. PubMed ID: 2455108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.